Literature DB >> 6267046

Hormonally sensitive cyclic AMP phosphodiesterase in liver cells. An ecto-enzyme.

J A Smoake, K L McMahon, R K Wright, S S Solomon.   

Abstract

Ecto-cyclic AMP phosphodiesterase activity was determined from freshly isolated and cultured liver cells. The cells were capable of hydrolyzing cyclic AMP in the medium. The ecto-phosphodiesterase represents a low Km phosphodiesterase which was activated by physiological concentrations of insulin. The product, 5'-AMP, was recovered in the medium and not with the cells. The enzyme was inhibited with aminophylline and trypsin. The ecto-phosphodiesterase activity was proportional to cell number, and total phosphodiesterase activity increased 5- to 10-fold when the cells were ruptured. About one-third of the ecto-phosphodiesterase activity from freshly isolated liver was due to phosphodiesterase in the medium. No phosphodiesterase was in the medium of cultured liver cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267046

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.

Authors:  T Chiavegatti; V L Costa; M S Araújo; R O Godinho
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

2.  A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism.

Authors:  Carly Jones; Malik Bisserier; Carlos Bueno-Beti; Guillaume Bonnet; Susana Neves-Zaph; Sang-Yong Lee; Javier Milara; Peter Dorfmüller; Marc Humbert; Jane A Leopold; Lahouaria Hadri; Roger J Hajjar; Yassine Sassi
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

Review 3.  New perspectives in signaling mediated by receptors coupled to stimulatory G protein: the emerging significance of cAMP efflux and extracellular cAMP-adenosine pathway.

Authors:  Rosely O Godinho; Thiago Duarte; Enio S A Pacini
Journal:  Front Pharmacol       Date:  2015-03-24       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.